20
Participants
Start Date
December 1, 2023
Primary Completion Date
May 8, 2024
Study Completion Date
May 8, 2024
200mg GCE +200mg ALA
200mg green coffee extract + 200mg alpha-lipoic acid
200mg GCE +400mg ALA
200mg green coffee extract + 400mg alpha-lipoic acid
200mg GCE + 200mg DHB
200mg green coffee extract + 200mg dihydroberberine
Placebo
microcrystalline cellulose with 5 mg magnesium stearate and 5 mg silicon dioxide
Queen's University, Kingston
Iovate Health Sciences International Inc
INDUSTRY
Dr. Chris McGlory, PhD
OTHER